Medical app is best seller

Published: 13-Jun-2011
Digital Pharmaceutical

Doctors at Evelina Children's Hospital in London have invented one of Europe's top-selling medical iPhone applications, with more than 100 downloads every week. The Paediatric Emergency Drugs app enables medical and nursing staff to quickly work out complicated drug calculations during emergencies to ensure paediatric patients receive the correct drug doses for their age and weight. Paediatric intensive care consultant, Dr Shelley Riphagen, came up with the idea with the help of Dr Andrew Durward's IT skills and the app went on sale in March this year. Dr Riphagen said: "When critically-ill children present to district general hospitals with emergencies, the right doses of drugs according to the child's age and weight need to be available immediately. The Paediatric Emergency Drugs app allows this to happen. It has made a huge difference to the care of our patients and it's really fantastic to know that it's also appreciated by medical and nursing staff in hospitals across Europe." The project was made possible through collaboration with UBQO.

See more

You may also like

Manufacturing

Nulogy launches Supplier Compliance Management to build stronger, more resilient supplier networks

Read more
Nulogy, a leading provider of manufacturing operations software, announced the launch of Nulogy Supplier Compliance Management, a solution designed to centralise and automate supplier compliance for procurement, supply chain, and quality assurance teams in manufacturing, food & beverage, pharmaceuticals, and other highly regulated industries

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Atrogi doses first subjects in human trial of exercise-mimicking oral therapy ATR-258 The Swedish biotech has initiated a human trial of ATR-258, a first-in-class oral β2-adrenergic receptor modulator designed to replicate the metabolic effects of exercise, including fat loss and muscle preservation, without the cardiovascular side effects associated with traditional β2-agonists
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    LGM Pharma announces $9 million investment into Colorado and Texas manufacturing facilities The investment marks the second phase of the the company's expansion, funding facility upgrades to increase capacity for suppository, semi-solid and oral solid dose and differentiating LGM in the US CDMO market, says CEO Prasad Raje, speaking exclusively to Manufacturing Chemist
  3. Lyocontract invests €50m in new freeze-drying facility with Syntegon vial line German CDMO Lyocontract has begun construction of a €50m expansion in Ilsenburg, partnering with Syntegon to install a complete vial filling and lyophilisation line for sterile freeze-dried pharmaceuticals
  4. Symeres awarded ISO/IEC 27001 certification as pharma clients demand stronger data security Drug discovery CRDMO Symeres has achieved ISO/IEC 27001 certification for information security management, as rising cybersecurity threats and stricter client due diligence requirements push data protection to the top of the outsourcing agenda
  5. Coriolis Pharma opens US headquarters and laboratory at Research Triangle Park in North Carolina Biopharmaceutical services specialist Coriolis Pharma has launched its first US base at the Alexandria Centre for Advanced Technologies, offering North American clients direct access to formulation development, particle analysis and drug product characterisation services

Upcoming event

Cleanroom Technology Awards 2026

13 April | Virtual See all

You may also like

Manufacturing

Nulogy launches Supplier Compliance Management to build stronger, more resilient supplier networks

Nulogy, a leading provider of manufacturing operations software, announced the launch of Nulogy Supplier Compliance Management, a solution designed to centralise and automate supplier compliance for procurement, supply chain, and quality assurance teams in manufacturing, food & beverage, pharmaceuticals, and other highly regulated industries
You need to be a subscriber to read this article.
Click here to find out more.
Digital

Digitalising the skills gap for biomanufacturing

The skills shortage is a growing issue for all manufacturing businesses, but is particularly relevant to biomanufacturing companies that require incredibly advanced skillsets
Regulatory

The challenges of developing combination products

Regulatory complexity and the case for a holistic development strategy
Ingredients

dsm-firmenich launches ModulaSENSE Bitter to tackle bitterness in oral drug formulations

The new taste modulation technology combines bitter blockers, maskers and sweeteners with receptor-based analysis to help pharmaceutical formulators improve the palatability of oral medicines
You need to be a subscriber to read this article.
Click here to find out more.
Analysis

Semaglutide patent cliff: pharma industry braces for impact

With the weight-loss industry shifting from a monopoly held by innovators to a high-volume, competitive generic market, the pharma manufacturing sector is gearing up for a "generic wave" with investments into large-scale protein synthesis and facilities for injectables
Design & Build

Entries closed: what’s next for the Cleanroom Technology Awards?

With entries now closed, attention turns to the next phase of the awards programme
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

LGM Pharma announces $9 million investment into Colorado and Texas manufacturing facilities

The investment marks the second phase of the the company's expansion, funding facility upgrades to increase capacity for suppository, semi-solid and oral solid dose and differentiating LGM in the US CDMO market, says CEO Prasad Raje, speaking exclusively to Manufacturing Chemist
Subscribe now